IP Library Granted Patent US 8,221,746
Granted Patent B2
US 8,221,746 · App. 12/434,409 · Granted Jul 17, 2012

Antioxidant for use in cosmetic, medicated and pharmaceutical preparations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,221,746
App. No.
12/434,409
Granted
Jul 17, 2012
Kind
B2
Abstract

The invention provides the use a 2,2-dimethyl chroman as a SOD mimetic in a cosmetic preparation. Cosmetic preparations comprising a 2,2-dimethyl chroman as a SOD mimetic are described, as well as methods for treating or preventing free radical damage to skin cells and treating or preventing hair loss which comprise topical administration of a 2,2-dimethyl chroman as a SOD mimetic.

Claims (14)

1. A cosmetic preparation comprising Lipochroman-6 (dimethyl methoxychromanol) as an antioxidant, wherein the Lipochroman-6 acts as a superoxide dismutase (SOD) mimetic, characterised in that the preparation further comprises one or more supplementary antioxidants selected from the group of catalase mimetics and derivatives thereof consisting of transition metal salts of PCA (pyrrolidone carboxylic acid), EUK-134 (chloro[[2,2′-[1,2-ethanediylbis[nitrilo-κN)methylidyne]]bis[6-methoxyphenolato-κO]]]-manganese), and propyl gallate.

2. A cosmetic preparation as claimed in claim 1 , in which the supplementary antioxidant is a transition metal salt of PCA.

3. A cosmetic preparation according to claim 2 , in which the transition metal salt of PCA is a copper PCA.

4. A cosmetic preparation according to claim 1 , in which the supplementary antioxidant is EUK-134.

5. A cosmetic preparation according to claim 1 , which is a gel, cream, shampoo or anhydrous preparation.

6. A cosmetic preparation according to claim 1 , in which the concentration of Lipochroman-6 is 0.1% or greater.

7. A cosmetic preparation as claimed in claim 1 , in which the cosmetic preparation is formulated in two parts comprising a first aqueous part and a second part comprising a cream or anhydrous base.

8. A cosmetic preparation as claimed in claim 7 , in which the first part is an aqueous gel comprising copper PCA and the second part is a cream or anhydrous base.

9. A cosmetic preparation as claimed in claim 8 , in which the first part comprises solubilised lipochroman-6 and one or more of copper PCA, propyl gallate and citric acid, and the second part comprises ascorbic acid and/or tetrasubstituted lipophilic ascorbate in an anhydrous base.

10. A cosmetic preparation as claimed in claim 1 , in which the pH of the cosmetic preparation is adjusted to 3 or below.

11. A cosmetic preparation as claimed in claim 1 , wherein the cosmetic preparation further comprises copper PCA and propyl gallate at a reduced pH.

12. A cosmetic preparation as claimed in claim 1 , wherein the cosmetic preparation further comprises a stabilizer selected from the group consisting of ferulic acid, butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), tert-butylhydroquinone (TBHQ), sodium metabisulphite (SMBS) and vitamin E.

13. A cosmetic preparation as claimed in claim 1 , wherein the cosmetic preparation further comprises one or more supplementary actives known to be beneficial in the treatment of hair loss or the promotion of hair growth selected from the group consisting of taurine, caffeine, saw palmetto, Pygeum africanum , Urtica dioica, minoxidil, azelaic acid, marine cartilage, hydrolysed keratin, biotin, niacin, panthenol, vitamin B6, zinc, copper peptides, horsetail silica, beta sitosterols, pycnogenol, white lupin, pumpkin seed, PABA, green tea extract, folic acid, iron, L-cysteine, magnesium and ginseng.

14. A cosmetic preparation as claimed in claim 1 further comprising ascorbic acid and/or tetrasubstituted lipophilic ascorbate in a single anhydrous formula.

Assignments (3)
CHANGE OF NAME Recorded Feb 28, 2024
From: PANGAEA LABORATORIES LIMITED
To: MEDIK8 LIMITED
Reel/Frame 066589/0472 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 022966 FRAME 0597. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT ASSIGNEE NAME FROM "PANGACA LABORATORIES LIMITED" TO "PANGAEA LABORATORIES LIMITED". Recorded Jul 27, 2009
From: ISAACS, ELLIOT JAMES; GREGORY, EMMA
To: PANGAEA LABORATORIES LIMITED
Reel/Frame 023011/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2009
From: ISAACS, ELLIOT JAMES; GREGORY, EMMA
To: PANGACA LABORATORIES LIMITED
Reel/Frame 022966/0597 →
Priority Claims (1)
EP 08155616 · May 2, 2008 · regional
Continuity (1)
Related Publication 20090274677A1 · Nov 5, 2009